Literature DB >> 19470978

FDA panel issues mixed decision on quetiapine in depression and anxiety.

Bridget M Kuehn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19470978     DOI： 10.1001/jama.2009.708

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

1.  Off-label use of atypical antipsychotics: cause for concern?

Authors:  Andrew McKean; Erik Monasterio
Journal:  CNS Drugs       Date:  2012-05-01       Impact factor: 5.749

2.  Dispensed prescriptions for quetiapine and other second-generation antipsychotics in Canada from 2005 to 2012: a descriptive study.

Authors:  Tamara Pringsheim; David M Gardner
Journal:  CMAJ Open       Date:  2014-10-01

3.  Quetiapine use in adults in the community: a population-based study in Alberta, Canada.

Authors:  Diane Duncan; Lara Cooke; Chris Symonds; David Gardner; Tamara Pringsheim
Journal:  BMJ Open       Date:  2016-03-21       Impact factor: 2.692

Review 4.  Cutaneous Lupus Erythematosus: Current and Future Pathogenesis-Directed Therapies.

Authors:  Alicia J Little; Matthew D Vesely
Journal:  Yale J Biol Med       Date:  2020-03-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.